Detalhe da pesquisa
1.
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
Mod Pathol
; 37(2): 100404, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104891
2.
Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.
Oncologist
; 28(2): 157-164, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200791
3.
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
Oncologist
; 28(1): 72-79, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124890
4.
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
Oncologist
; 28(7): 642-e561, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134294
5.
Current Status and Future Direction to Address Disparities in Diversity, Equity, and Inclusion in Prostate Cancer Care.
Curr Oncol Rep
; 25(7): 699-708, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37010786
6.
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delays.
Support Care Cancer
; 32(1): 13, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060063
7.
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data.
Cancer
; 128(24): 4194-4202, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251574
8.
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis.
J Urol
; 208(1): 71-79, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212574
9.
Safety of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and malignant ureteric obstruction.
BJU Int
; 129(3): 364-372, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780097
10.
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.
J Natl Compr Canc Netw
; 20(2): 160-166, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130494
11.
The past, present, and future of pT0 in bladder cancer clinical trials.
Curr Opin Urol
; 32(5): 495-499, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35855573
12.
Temporal trends of adverse events and costs of nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma.
Future Oncol
; 18(10): 1219-1234, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939424
13.
Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial.
Support Care Cancer
; 30(3): 2803-2810, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845502
14.
Comparing Perceptions and Decisional Conflict Towards Participation in Cancer Clinical Trials Among African American Patients Who Have and Have Not Participated.
J Cancer Educ
; 37(2): 395-404, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654038
15.
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(4): 525-537, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721560
16.
Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial.
J Urol
; 205(6): 1605-1611, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535799
17.
Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial.
J Urol
; 204(3): 531-537, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250730
18.
Using theory and user-centered design in digital health: The development of the mychoice communication tool to prepare patients and improve informed decision making regarding clinical trial participation.
Psychooncology
; 29(1): 114-122, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654442
19.
Incidentally discovered primary mediastinal germ cell tumor.
JAAPA
; 33(4): 35-37, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32217905
20.
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Lancet Oncol
; 20(4): 581-590, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827746